Inclusion criteria |
Study conducted in the Greater Mekong region (Cambodia, Laos, Vietnam, Thailand, Myanmar and the Yunnan Province of the People’s Republic of China). |
|
Study including patients (or a clear subset of patients). |
|
Patients tested by laboratory analysis (serology, molecular methods, culture or antigen tests) performed in a laboratory setting. |
Exclusion criteria |
No abstract or free full text access available. |
|
Editorial or opinion rather than publication of new data. |
|
Economic impact studies of febrile illnesses without pathological testing. |
|
Follow-up studies (cohort of patients already described in a previous study). |
|
Animal studies. |
|
Experimental (in vitro or in vivo cellular, molecular, biochemical studies or other studies that do not involve patients). |
|
Vaccine and drug trials. |
|
Modeling studies. |
|
Laboratory methods descriptions. |
|
Case reports and studies of biochemical or clinical outcomes only (e.g. liver function, pathology, disease features, clinical presentation of a disease). |
|
Biomarker evaluation. |
|
Travel (acute febrile illnesses associated with a travel episode, as place of infection may be in doubt). |
|
Other studies of disease not including identification of causes of fever (e.g. demographic surveillance, geographic information, vector transmission, climate impact). |